{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:59:05Z","timestamp":1790438345257,"version":"4.1.0"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000294","name":"Medical Research Scotland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2019.01365","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T04:41:23Z","timestamp":1573792883000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Refining the Mouse Subtotal Nephrectomy in Male 129S2\/SV Mice for Consistent Modeling of Progressive Kidney Disease With Renal Inflammation and Cardiac Dysfunction"],"prefix":"10.3389","volume":"10","author":[{"given":"James","family":"O\u2019Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Louise","family":"Finnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Teenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolynn","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"B\u00e9n\u00e9zech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan Ronald","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Denby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities.","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1525-139X.2009.00575.x","article-title":"The general picture of uremia.","volume":"22","author":"Almeras","year":"2009","journal-title":"Semin. Dial."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2215\/CJN.13121215","article-title":"Inflammation and progression of CKD: the CRIC study.","volume":"11","author":"Amdur","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1172\/jci112528","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.","volume":"77","author":"Anderson","year":"1986","journal-title":"J. Clin. Invest."},{"key":"B5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.freeradbiomed.2012.06.027","article-title":"Role of Nox4 in murine models of kidney disease.","volume":"53","author":"Babelova","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kint.2018.12.028","article-title":"MicroRNA-214 promotes chronic kidney disease by disrupting mitochondrial oxidative phosphorylation.","volume":"95","author":"Bai","year":"2019","journal-title":"Kidney Int."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11852","article-title":"Long-lived self-renewing bone marrow-derived macrophages displace embryo-derived cells to inhabit adult serous cavities.","volume":"7","author":"Bain","year":"2016","journal-title":"Nat. Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.4161\/15548627.2014.981786","article-title":"Autophagy fosters myofibroblast differentiation through MTORC2 activation and downstream upregulation of CTGF.","volume":"10","author":"Bernard","year":"2014","journal-title":"Autophagy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1152\/ajprenal.00392.2012","article-title":"Target organ cross talk in cardiorenal syndrome: animal models.","volume":"303","author":"Bongartz","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrneph.2010.120","article-title":"Renal fibrosis: novel insights into mechanisms and therapeutic targets.","volume":"6","author":"Boor","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/9780470942390.mo110217","article-title":"Health evaluation of experimental laboratory mice.","volume":"2","author":"Burkholder","year":"2012","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1681\/ASN.2018050515","article-title":"Quantity and reporting quality of kidney research.","volume":"30","author":"Chatzimanouil","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003205","article-title":"MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways.","volume":"4","author":"Chau","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1681\/ASN.2014111138","article-title":"Differential Ly6C expression after renal ischemia-reperfusion identifies unique macrophage populations.","volume":"27","author":"Clements","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/cbin.10787","article-title":"Fibrillar collagen genes are not coordinately upregulated with TGF \u03b21 expression in finasteride-treated prostate.","volume":"41","author":"Delella","year":"2017","journal-title":"Cell Biol. Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1681\/ASN.2013010072","article-title":"MicroRNA-214 antagonism protects against renal fibrosis.","volume":"25","author":"Denby","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ajpath.2011.04.021","article-title":"miR-21 and miR-214 are consistently modulated during renal injury in rodent models.","volume":"179","author":"Denby","year":"2011","journal-title":"Am. J. Pathol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10741-014-9460-9","article-title":"Chronic kidney disease and cardiovascular complications.","volume":"20","author":"Di","year":"2015","journal-title":"Hear. Fail Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"F1523","DOI":"10.1152\/ajprenal.00426.2009","article-title":"Effect of ACE2 and angiotensin-(1\u20137) in a mouse model of early chronic kidney disease.","volume":"298","author":"Dilauro","year":"2010","journal-title":"Am J Physiol Ren. Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/sj.ki.5000212","article-title":"The relationship between albuminuria, MCP-1\/CCL2, and interstitial macrophages in chronic kidney disease.","volume":"69","author":"Eardley","year":"2006","journal-title":"Kidney Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: from subspecialty to global health burden.","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.","volume":"63","author":"Feldman","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/sdi.12411","article-title":"Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease.","volume":"28","author":"Felsenfeld","year":"2015","journal-title":"Semin. Dial."},{"key":"B24","first-page":"28","article-title":"Guidelines for assessing the health and condition of mice.","volume":"28","author":"Foltz","year":"1999","journal-title":"Lab. Anim."},{"key":"B25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000430475","article-title":"Arrhythmogenic remodeling in murine models of deoxycorticosterone acetate-salt-induced and 5\/6-subtotal nephrectomy-salt-induced cardiorenal disease.","volume":"5","author":"Fontes","year":"2015","journal-title":"CardioRenal Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/9780470942390.mo100130","article-title":"Murine echocardiography.","volume":"1","author":"Gao","year":"2011","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"B27","first-page":"167","article-title":"Effects of 5\/6 nephrectomy on renal function and blood pressure in mice.","volume":"4","author":"Gava","year":"2012","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.kint.2016.08.025","article-title":"Progression of chronic kidney disease: too much cellular talk causes damage.","volume":"91","author":"Gewin","year":"2017","journal-title":"Kidney Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.matbio.2018.02.006","article-title":"Renal fibrosis: primacy of the proximal tubule.","volume":"6","author":"Gewin","year":"2018","journal-title":"Matrix Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1172\/jci75852","article-title":"Anti\u2013microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways.","volume":"125","author":"Gomez","year":"2015","journal-title":"J. Clin. Invest."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-016-0769-y","article-title":"Blood pressure targets in CKD: lessons learned from sprint and previous observational studies.","volume":"18","author":"Gosmanova","year":"2016","journal-title":"Curr. Cardiol. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2215\/CJN.11511114","article-title":"Albuminuria Is an appropriate therapeutic target in patients with CKD: the pro view.","volume":"10","author":"Heerspink","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/srep27209","article-title":"miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy.","volume":"6","author":"Hennino","year":"2016","journal-title":"Sci. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"F1239","DOI":"10.1152\/ajprenal.90521.2008","article-title":"Renal tubulointerstitial fibrosis: common but never simple.","volume":"296","author":"Hewitson","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00465","article-title":"Animal models to study links between cardiovascular disease and renal failure and their relevance to human pathology.","volume":"6","author":"Hewitson","year":"2015","journal-title":"Front. Immunol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00520","article-title":"Progression of tubulointerstitial fibrosis and the chronic kidney disease phenotype - role of risk factors and epigenetics.","volume":"8","author":"Hewitson","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease \u2013 a systematic review and meta-analysis.","volume":"6","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1053\/j.ackd.2014.09.004","article-title":"Epidemiology of hypertension in CKD.","volume":"22","author":"Horowitz","year":"2015","journal-title":"Adv. Chronic Kidney Dis."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102096","article-title":"Axl tyrosine kinase protects against tubulo-interstitial apoptosis and progression of renal failure in a murine model of chronic kidney disease and hyperphosphataemia.","volume":"9","author":"Hyde","year":"2014","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ndt\/gfi303","article-title":"In mice, proteinuria and renal inflammatory responses to albumin overload are strain-dependent.","volume":"21","author":"Ishola","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"B41","doi-asserted-by":"crossref","first-page":"F1283","DOI":"10.1152\/ajprenal.00441.2003","article-title":"Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats.","volume":"287","author":"Ito","year":"2004","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives.","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1242\/dmm.021741","article-title":"ER stress and basement membrane defects combine to cause glomerular and tubular renal disease resulting from Col4a1 mutations in mice.","volume":"9","author":"Jones","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability.","volume":"63","author":"J\u00f6rres","year":"2004","journal-title":"Kidney Int."},{"key":"B45","doi-asserted-by":"crossref","first-page":"F450","DOI":"10.1152\/ajprenal.00472.2007","article-title":"Partial nephrectomy as a model for uremic cardiomyopathy in the mouse.","volume":"294","author":"Kennedy","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.115.002423","article-title":"Natriuretic peptides in the regulation of cardiovascular physiology and metabolic events.","volume":"4","author":"Kerkel\u00e4","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"iii73","DOI":"10.1093\/ndt\/gfs269","article-title":"Estimating the financial cost of chronic kidney disease to the NHS in England.","volume":"27","author":"Kerr","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"B48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.stem.2014.11.004","article-title":"Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis.","volume":"16","author":"Kramann","year":"2015","journal-title":"Cell Stem Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1046\/j.1523-1755.1999.00527.x","article-title":"The course of the remnant kidney model in mice.","volume":"56","author":"Kren","year":"1999","journal-title":"Kidney Int."},{"key":"B50","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.0894-0959.2004.17604.x","article-title":"C-reactive protein and end-stage renal disease.","volume":"17","author":"Lacson","year":"2004","journal-title":"Semin. Dial."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1042\/cs20160203","article-title":"Urea, a true uremic toxin: the empire strikes back.","volume":"131","author":"Lau","year":"2016","journal-title":"Clin. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/ki.2010.287","article-title":"Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.","volume":"78","author":"Leelahavanichkul","year":"2010","journal-title":"Kidney Int."},{"key":"B53","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1053\/j.ajkd.2013.12.006","article-title":"GFR estimation: from physiology to public health.","volume":"63","author":"Levey","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.5830\/CVJA-2011-069","article-title":"P53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney disease.","volume":"23","author":"Li","year":"2012","journal-title":"Cardiovasc. J. Afr."},{"key":"B55","doi-asserted-by":"publisher","first-page":"934","DOI":"10.4049\/jimmunol.182.2.934","article-title":"Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease.","volume":"182","author":"Lin","year":"2009","journal-title":"J. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"H733","DOI":"10.1152\/ajpheart.00339.2017","article-title":"Guidelines for measuring cardiac physiology in mice.","volume":"314","author":"Lindsey","year":"2018","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"F974","DOI":"10.1152\/ajprenal.00624.2017","article-title":"Heart-kidney interactions: mechanistic insights from animal models.","volume":"316","author":"Liu","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/ndt\/17.5.723","article-title":"Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia.","volume":"17","author":"Locatelli","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"B59","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1152\/physiolgenomics.00039.2017","article-title":"Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.","volume":"50","author":"Lv","year":"2018","journal-title":"Physiol. Genom."},{"key":"B60","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1046\/j.1523-1755.2003.00058.x","article-title":"Model of robust induction of glomerulosclerosis in mice: importance of genetic background.","volume":"64","author":"Ma","year":"2003","journal-title":"Kidney Int."},{"key":"B61","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ki.2014.287","article-title":"Origin of myofibroblasts and cellular events triggering fibrosis.","volume":"87","author":"Mack","year":"2015","journal-title":"Kidney Int."},{"key":"B62","doi-asserted-by":"publisher","first-page":"440","DOI":"10.2215\/CJN.05130610","article-title":"Prevention and control of phosphate retention\/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?","volume":"6","author":"Martin","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0002-9343(85)90077-4","article-title":"Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency.","volume":"79","author":"Meyer","year":"1985","journal-title":"Am. J. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines.","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"B65","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40139-013-0025-8","article-title":"Myofibroblasts in fibrotic kidneys.","volume":"1","author":"Nakagawa","year":"2013","journal-title":"Curr. Pathobiol. Rep."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136994","article-title":"Molecular markers of tubulointerstitial fibrosis and tubular cell damage in patients with chronic kidney disease.","volume":"10","author":"Nakagawa","year":"2015","journal-title":"PLoS One"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0272-6386(12)80312-x","article-title":"Tubulointerstitial changes as a major determinant in the progression of renal damage.","volume":"20","author":"Nath","year":"1992","journal-title":"Am. J. Kidney Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.semnephrol.2019.02.009","article-title":"CKD hotspots: challenges and areas of opportunity.","volume":"39","author":"Obrador","year":"2019","journal-title":"Semin. Nephrol."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0555-0","article-title":"T-cells contribute to hypertension but not to renal injury in mice with subtotal nephrectomy.","volume":"18","author":"Oosterhuis","year":"2017","journal-title":"BMC Nephrol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1081\/jdi-100104737","article-title":"C reactive protein in patients with chronic renal diseases.","volume":"23","author":"Panichi","year":"2001","journal-title":"Ren. Fail."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1681\/asn.2006080872","article-title":"Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.","volume":"18","author":"Perkins","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.4377","article-title":"Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5.","volume":"177","author":"Peters","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.113.000405","article-title":"Glycosaminoglycan overproduction in the aorta increases aortic calcification in murine chronic kidney disease.","volume":"2","author":"Purnomo","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"B74","doi-asserted-by":"publisher","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","article-title":"Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis.","volume":"109","author":"Ramachandran","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B75","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ki.1985.197","article-title":"Myocardial hypertrophy in rats with renal insufficiency.","volume":"28","author":"Rambausek","year":"1985","journal-title":"Kidney Int."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3791\/1738","article-title":"Transthoracic echocardiography in mice.","volume":"39","author":"Respress","year":"2010","journal-title":"J. Vis. Exp."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2015.06.029","article-title":"Atrial natriuretic peptide in cardiovascular biology and disease (NPPA).","volume":"569","author":"Riaz","year":"2015","journal-title":"Gene"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2215\/CJN.11901115","article-title":"Phosphate toxicity in CKD: the killer among us.","volume":"11","author":"Ritter","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1111\/bph.14509","article-title":"Adaptive immunity and IL-17A are not involved in the progression of chronic kidney disease after 5\/6 nephrectomy in mice.","volume":"176","author":"Rosendahl","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00467-015-3169-4","article-title":"Tubular atrophy in the pathogenesis of chronic kidney disease progression.","volume":"31","author":"Schelling","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.yjmcc.2017.10.006","article-title":"Echocardiographic evaluation of diastolic function in mouse models of heart disease.","volume":"114","author":"Schnelle","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ki.2008.690","article-title":"Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure.","volume":"75","author":"Siedlecki","year":"2009","journal-title":"Kidney Int."},{"key":"B83","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1113\/expphysiol.2007.041350","article-title":"Angiotensin-converting enzyme 2 and the kidney.","volume":"93","author":"Soler","year":"2008","journal-title":"Exp. Physiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/ndt\/gfn626","article-title":"Serum cystatin C in mouse models: a reliable and precise marker for renal function and superior to serum creatinine.","volume":"24","author":"Song","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"B85","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/0886022X.2019.1627220","article-title":"An optimized 5\/6 nephrectomy mouse model based on unilateral kidney ligation and its application in renal fibrosis research.","volume":"41","author":"Tan","year":"2019","journal-title":"Ren. Fail."},{"key":"B87","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1146\/annurev.immunol.23.021704.115816","article-title":"Macrophage receptors and immune recognition.","volume":"23","author":"Taylor","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s11255-013-0520-1","article-title":"Unilateral ureteral obstruction: beyond obstruction.","volume":"46","author":"Ucero","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"B89","first-page":"319","article-title":"Body condition scoring: a rapid and accurate method for assessing health status in mice.","volume":"49","author":"Ullman-Culler\u00e9","year":"1999","journal-title":"Lab. Anim. Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ndt\/gfx039","article-title":"Urea and chronic kidney disease: the comeback of the century? (in uraemia research).","volume":"33","author":"Vanholder","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.08.025","article-title":"Practical approach to detection and management of chronic kidney disease for the primary care clinician.","volume":"129","author":"Vassalotti","year":"2016","journal-title":"Am. J. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"F1047","DOI":"10.1152\/ajprenal.00325.2015","article-title":"Renal endothelial function is associated with the anti-proteinuric effect of ACE inhibition in 5\/6 nephrectomized rats.","volume":"310","author":"Vavrinec","year":"2016","journal-title":"Am. J. Physiol. Physiol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1681\/ASN.2015010006","article-title":"Failed tubule recovery, AKI-CKD transition, and kidney disease progression.","volume":"26","author":"Venkatachalam","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrneph.2016.164","article-title":"The role of phosphate in kidney disease.","volume":"13","author":"Vervloet","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1053\/j.ajkd.2012.03.011","article-title":"Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the atherosclerosis risk in communities (ARIC) study.","volume":"60","author":"Waheed","year":"2012","journal-title":"Am. J. Kidney Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-4939-7030-8_6","article-title":"Measuring blood pressure using a noninvasive tail cuff method in mice.","volume":"1614","author":"Wang","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease.","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"B98","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejphar.2007.10.060","article-title":"Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5\/6 nephrectomized rats.","volume":"580","author":"Windt","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"B99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ddmod.2010.08.002","article-title":"Models of chronic kidney disease.","volume":"7","author":"Yang","year":"2010","journal-title":"Drug Discov. Today Dis. Model."},{"key":"B100","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1074\/jbc.ra117.000559","article-title":"Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease\u2013accelerated atherosclerosis.","volume":"293","author":"Zeng","year":"2018","journal-title":"J. Biol. Chem."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2019.01365\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T04:41:42Z","timestamp":1573792902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2019.01365\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":100,"alternative-id":["10.3389\/fphys.2019.01365"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2019.01365","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]},"article-number":"1365"}}